Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • wilderguide wilderguide Sep 11, 2011 10:05 PM Flag

    Phase 1 MTC data review: question , Pt 1

    ...later treated w/ CABO. Activity noted. Interesting, no?
    My conjecture is that either the AE was too stressful...or the vandetanib less than effective... Is it a sound inference to suggest that-for some patients-CABO may prove to be a best,if only more effective choice.
    Conversely, I have been looking for a former CABO recipient...currently treated w/ vandetanib. I can find no evidence of this...
    Anyone...?

 
EXEL
7.81+0.01(+0.13%)Jun 30 4:00 PMEDT